Early Clinical Experience with a Hybrid Bioartificial Liver

References

• Pappas SC. Fulminant hepatic failure and need for artificial liver support. Mayo Clin Proc 1988; 63: 198–200
   PubMedGoogle Scholar
• Burnell JM, Runge C, Saunders FC, Thomas ED, Volwiler W. Acute hepatic failure treated by cross circulation. Arch Intern Med 1973; 132: 493–8
   PubMed Web of Science ®Google Scholar
• Bihari D, Hughes R D, Gimson A ES, Langley P G, Ede R J, Eder G, et al. Effects of serial resin heraoperfusion in fulminant hepatic failure. Int J Artif Organs 1983; 6: 299–302
   PubMed Web of Science ®Google Scholar
• Parbhoo S P, James I M, Ajdukiewicz A, Xanalatos C, Kennedy J, Chalstrey L J, et al. Extracorporeal pig-liver perfusion in treatment of hepatic coma due to fulminant hepatitis. Lancet 1971; 1: 659–65
   PubMedGoogle Scholar
• Abouna G M, Cook J S, Fisher L MA, Still W J, Costa G, Hume D M, et al. Treatment of acute hepatic coma by ex vivo baboon and human liver perfusions. Surgery 1972; 71: 537–46
   PubMed Web of Science ®Google Scholar
• Gimson A ES, Braude S, Mellon P J, Canalese J, Williams R. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet 1982; 2: 681–3
   PubMed Web of Science ®Google Scholar
• Smith J W, Matsubara S, Horiuchi T, Kayashima K, Shinagawa S, Malchesky PS. Sorption-filtration therapy for chronic liver disease: in vitro testing and clinical correlation. Trans Am Soc Artif Intern Organs 1982; 28: 215–9
   PubMedGoogle Scholar
• Silk D BA, Trewby P N, Chase R A, Mellon P J, Hanid M A, Davies M, et al. Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis. Lancet 1977; 2: 1–3
   PubMed Web of Science ®Google Scholar
• Denis J, Opolon P, Nusinovici V, Granger A, Darnis F. Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane. Gut 1978; 19: 787–93
   PubMedGoogle Scholar
• Redeker A G, Yamahiro HS. Controlled trial of exchange-transfusion therapy in fulminant hepatitis. Lancet 1973; 2: 3–6
   Google Scholar
• Cooper GN, Jr, Karlson K E, Clowes G HA, Martin H, Randall HT. Total body washout and exchange. A valuable tool in acute hepatic coma and Reye's syndrome. Am J Surg 1977; 133: 522–30
   PubMedGoogle Scholar
• Denti E, Luboz MP. Preparation and properties of gel-entrapped liver cell microsomes. Articifial liver support, R Williams, I M Murray-Lyon. Pitman Medical, U.K. 1974; 148–52
   Google Scholar
• Usami M, Ohyanagi H, Nishimatsu S, Kasahara H, Shiroiwa H, Ishimoto S, et al. Therapeutic plasmapheresis for liver failure after hepatectomy. Trans Am Soc Artif Intern Organs 1989; 35: 564–7
   Google Scholar
• Olumide F, Eliashiv A, Kralios N, Norton L, Eiseman B. Hepatic support with hepatocyte suspensions in a permeable membrane dialyzer. Surgery 1977; 82: 599–606
   PubMedGoogle Scholar
• Yanagi K, Ookawa K. M. Performance of a new hybrid artificial liver support system using hepatocytes entrapped within a hydro-gel. Trans Am Soc Artif Intern Organs 1989; 35: 570–2
   Google Scholar
• Matsumura K N, Guevara G R, Huston H, Hamilton W L, Rikimaru M, Vamasaki G, et al. Hybrid bioartificial liver in hepatic failure: preliminary clinical report. Surgery 1987; 101: 99–103
   PubMed Web of Science ®Google Scholar
• Saito S, Sakagami K, Orita K. A new hybrid artificial liver using a combination of hepatocytes and biomatrix. Trans Am Soc Artif Intern Organs 1987; 33: 459–62
   Google Scholar
• O'Grady J G, Gimson A ES, O'Brien C J, Pucknell A, Hughes R D, Williams R. Controlled trial of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 1186–92
   PubMed Web of Science ®Google Scholar
• Friend P J, Lim S, Smith M, Jamieson N V, Rolles K, O'Grady J G, et al. Liver transplantation in the Cambridge/King's College Hospital series: the first 400 patients. Transplant Proc 1989; 21: 2397–8
   PubMedGoogle Scholar
• Ascher N L, Lake J R, Emond J C, Roberts JP. Liver transplantation for fulminant hepatic failure. Arch Surg 1993; 128: 677–82
   PubMedGoogle Scholar
• Rozga J, Williams F, Ro M S, Neuzil D F, Giorgio T O, Backfish G, et al. Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells. Hepatology 1993; 17: 258–65
   PubMed Web of Science ®Google Scholar
• Rozga J, Holzman M D, Ro M S, Griffin D W, Neuzil D F, Giorgio T, et al. Development of a hybrid bioartificial liver. Ann Surg 1993; 217: 502–11
   PubMed Web of Science ®Google Scholar
• Neuzil D F, Rozga J, Moscioni A D, Ro M S, Hakim R, Arnaout W S, et al. Use of a novel bioartificial liver in a patient with acute liver insufficiency. Surgery 1993; 113: 340–3
   PubMed Web of Science ®Google Scholar
• Rozga J, Podesta L, Le Page E, Hoffman A, Morsiani E, Sher L, et al. Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet 1993; 342: 898–9
   PubMed Web of Science ®Google Scholar
• Matsubara S, Okabe K, Ouche K, Miyazaki Y, Yajima Y, Suzuki H, et al. Continuous removal of middle molecules by hemofiltration in patients with acute liver failure. Crit Care Med 1990; 18: 1331–8
   PubMed Web of Science ®Google Scholar
• Silk D BA, Trewby P N, Chase RA. Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis. Lancet 1977; 2: 1–3
   PubMed Web of Science ®Google Scholar
• Knazek R A, Gullino P M, Kohler J, Dedrick RL. Cell culture on artificial capillaries: an approach to tissue growth in vitro. Science 1972; 178: 65–6
   PubMedGoogle Scholar
• Wolf C FW, Munkelt BF. Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries. Trans Am Soc Artif Intern Organs 1975; 21: 16–27
   PubMedGoogle Scholar
• Hager J C, Carman R, Stoller R, Panol G, Leduc E H, Thayer W R, et al. A prototype for a hybrid artificial liver. Trans Am Soc Artif Intern Organs 1978; 24: 250–3
   PubMedGoogle Scholar
• Kawarabata J, Yoshida M, Suzuki T, et al. Studies on extracorporeal liver support. I: Preliminary studies using isolated rabbit liver cells. Jpn J Artif Organs 1977; 6: 468–71
   Google Scholar
• Eiseman B, Norton L, Kralios NC. Hepatocyte perfusion within a centrifuge. Surg Gynecol Obst 1976; 142: 21–8
   PubMedGoogle Scholar
• Brunner G, Holloway C J, Losgen H. The application of immobilized enzymes in an artificial liver support system. Artif Organs 1979; 3: 27–30
   PubMedGoogle Scholar
• Demetriou A A, Whiting J, Levenson S M, Chowdhury N R, Scheduler R, Michalski S, et al. New method of hepatocyte transplantation and extracorporeal liver support. Ann Surg 1986; 204: 259–71
   PubMed Web of Science ®Google Scholar
• Dunn J CY, Tompkins R G, Yarmush ML. Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol Prog 1991; 7: 237–45
   PubMed Web of Science ®Google Scholar
• Moscioni A D, Backfisch G, Bellew T, et al. Long-term cryopreserved human hepatocytes maintain drug metabolizing ability. Surg Forum 1990; 41: 3–4
   Google Scholar
• Nyberg S L, Shatford R A, Peshwa M V, et al. Evaluation of a hepatocyte-entrapment hollow-fiber bioreactor: a potential bioartificial liver. Biotechnol Bioeng 1993; 41: 194–203
   PubMed Web of Science ®Google Scholar
• Nyberg S L, Mann H J, Remmel R P, Hu W S, Cerra FB. Pharmacokinetic analysis verifies P-450 function during in vitro and in vivo application of a bioartificial liver. ASAIO J 1993; 39: M252–6
   Google Scholar
• Shnyra A, Bocharov A, Bochkova N, Spirov V. Bioartificial liver using hepatocytes on biosilon microcarriers: treatment of chemically induced acute hepatic failure in rats. Artif Organs 1991; 15: 189–97
   PubMedGoogle Scholar
• Sussman N L, Kelly JH. Improved liver function following treatment with an extracorporeal liver assist device. Artif Organs 1993; 17: 27–30
   PubMedGoogle Scholar
• Sussman N L, Chong M G, Koussayer T, He D E, Shang T A, Whisennand H H, et al. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 1992; 16: 60–5
   PubMed Web of Science ®Google Scholar
• Wada G, Oshima N. Improvement of the performance of a hybrid-type artificial liver utilizing isolated hepatocytes: the use of conditioned medium. Jpn J Artif Organs 1985; 14: 241–4
   Google Scholar
• Jauregui H O, Santangini H, Naik S. In vitro benzodiazepine metabolism of adult rat hepatocytes seeded in a hollow-fiber membrane device. Hepatology 1988; 8: 1387
   Google Scholar
• Arnaout W S, Moscioni A D, Barbour R L, Demetriou AA. Development of bioartificial liver: bilirubin conjugation in Gunn rats. J Surg Res 1990; 48: 379–82
   PubMed Web of Science ®Google Scholar
• Margulis M S, Erukhimov E A, Andreiman L A, Viksna LM. Temporary organ substitution by hemoperfusion through suspension of active donor hepatocytes in a total complex of intensive therapy in patients with acute hepatic insufficiency. Resuscitation 1989; 18: 85–94
   PubMed Web of Science ®Google Scholar
• Rojkind M, Gatmaitan Z, Mackensen S, Giambron M A, Ponche P, Reid LM. Connective tissue biomatrix: its isolation and utilization for long-term cultures of normal rat hepatocytes. J Cell Biol 1980; 87: 255–63
   PubMed Web of Science ®Google Scholar
• Caron JM. Induction of albumin gene transcription in hepatocytes byextracellular matrix proteins. Mol Cell Biol 1990; 10: 1239–43
   PubMedGoogle Scholar
• Gove C D, Hughes R D, Williams R. Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat livers by serum from patients with fulminant hepatic failure. Br J Exp Pathol 1982; 63: 547–61
   PubMedGoogle Scholar
• Gerlach J, Kloppel K, Stoll P, Vienken J, Müller C. Gas supply across membranes in bioreactors for hepatocyte culture. Artif Organs 1990; 14: 328–33
   PubMedGoogle Scholar